Liu Won-Shiung, Chen Chun-Ta, Foo Ning-Hui, Huang Hsuan-Rong, Wang Jhi-Joung, Chen Sheng-Hsien, Chen Te-Jen
Department of Pediatrics, Chi Mei Medical Center, Tainan, Taiwan.
Pediatr Neonatol. 2009 Oct;50(5):208-16. doi: 10.1016/S1875-9572(09)60065-6.
Intravenous administration of human umbilical cord blood cells (HUCBC) has been shown to improve heatstroke by reducing arterial hypotension as well as cerebral ischemia and damage in a rat model. To extend these findings, we assessed both hypothalamic neuronal apoptosis and systemic inflammatory responses in the presence of HUCBCs or vehicle medium immediately after initiation of heatstroke.
Anesthetized rats, immediately after the initiation of heat stress, were divided into two groups and given either serum-free lymphocyte medium (0.3mL per rat, intravenously) or HUCBCs (5 x 10(6) in 0.3 mL serum-free lymphocyte medium, intravenously). Another group of rats were exposed to room temperature (26 degrees C) and used as normothermic controls. Heatstroke was induced by exposing the anesthetized rats to a high ambient temperature of 43 degrees C for 68 minutes.
After the onset of heatstroke, animals treated with serum-free lymphocyte medium displayed hyperthermia, hypotension, bradycardia, hypothalamic neuronal apoptosis and degeneration, and up-regulation of systemic inflammatory response molecules including serum tumor necrosis factor-alpha, soluble intercellular adhesion molecule-1 and E-selectin. Heatstroke-induced hypotension, bradycardia, hypothalamic neuronal apoptosis and degeneration, and increased systemic inflammatory response molecules were significantly inhibited by HUCBC treatment. Although heatstroke-induced hyperthermia was not affected by HUCBC treatment, the serum levels of the anti-inflammatory cytokine interleukin-10 were significantly increased by HUCBC therapy during hyperthermia.
These findings suggest that HUCBC transplantation may prevent the occurrence of heatstroke by reducing hypothalamic neuronal damage and the systemic inflammatory responses.
在大鼠模型中,静脉注射人脐带血细胞(HUCBC)已被证明可通过减轻动脉低血压以及脑缺血和损伤来改善中暑情况。为扩展这些发现,我们在中暑开始后立即评估了存在HUCBC或空白培养基时下丘脑神经元凋亡和全身炎症反应。
麻醉后的大鼠在热应激开始后立即分为两组,分别静脉注射无血清淋巴细胞培养基(每只大鼠0.3mL)或HUCBC(5×10⁶个细胞于0.3mL无血清淋巴细胞培养基中,静脉注射)。另一组大鼠暴露于室温(26℃)下作为正常体温对照。通过将麻醉后的大鼠暴露于43℃的高环境温度下68分钟来诱导中暑。
中暑发作后,接受无血清淋巴细胞培养基治疗的动物出现体温过高、低血压、心动过缓、下丘脑神经元凋亡和退化,以及全身炎症反应分子上调,包括血清肿瘤坏死因子-α、可溶性细胞间黏附分子-1和E-选择素。HUCBC治疗可显著抑制中暑诱导的低血压、心动过缓、下丘脑神经元凋亡和退化以及全身炎症反应分子增加。虽然中暑诱导的体温过高不受HUCBC治疗影响,但在体温过高期间,HUCBC治疗可显著提高抗炎细胞因子白细胞介素-10的血清水平。
这些发现表明,HUCBC移植可能通过减少下丘脑神经元损伤和全身炎症反应来预防中暑的发生。